"T-Lymphocytes" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen.
| Descriptor ID |
D013601
|
| MeSH Number(s) |
A11.118.637.555.567.569 A15.145.229.637.555.567.569 A15.382.490.555.567.569
|
| Concept/Terms |
T-Lymphocytes- T-Lymphocytes
- T Lymphocytes
- T-Lymphocyte
- T-Cells
- T Cells
- T-Cell
- Thymus-Dependent Lymphocytes
- Lymphocyte, Thymus-Dependent
- Lymphocytes, Thymus-Dependent
- Thymus Dependent Lymphocytes
- Thymus-Dependent Lymphocyte
|
Below are MeSH descriptors whose meaning is more general than "T-Lymphocytes".
Below are MeSH descriptors whose meaning is more specific than "T-Lymphocytes".
This graph shows the total number of publications written about "T-Lymphocytes" by people in this website by year, and whether "T-Lymphocytes" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 13 | 10 | 23 |
| 1994 | 12 | 9 | 21 |
| 1995 | 16 | 9 | 25 |
| 1996 | 8 | 6 | 14 |
| 1997 | 13 | 7 | 20 |
| 1998 | 15 | 9 | 24 |
| 1999 | 19 | 10 | 29 |
| 2000 | 5 | 10 | 15 |
| 2001 | 20 | 7 | 27 |
| 2002 | 17 | 18 | 35 |
| 2003 | 20 | 12 | 32 |
| 2004 | 19 | 12 | 31 |
| 2005 | 12 | 9 | 21 |
| 2006 | 18 | 6 | 24 |
| 2007 | 16 | 15 | 31 |
| 2008 | 11 | 7 | 18 |
| 2009 | 17 | 16 | 33 |
| 2010 | 10 | 14 | 24 |
| 2011 | 18 | 9 | 27 |
| 2012 | 12 | 15 | 27 |
| 2013 | 20 | 12 | 32 |
| 2014 | 17 | 19 | 36 |
| 2015 | 19 | 16 | 35 |
| 2016 | 13 | 17 | 30 |
| 2017 | 10 | 10 | 20 |
| 2018 | 16 | 12 | 28 |
| 2019 | 14 | 7 | 21 |
| 2020 | 16 | 7 | 23 |
| 2021 | 7 | 12 | 19 |
| 2022 | 7 | 12 | 19 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "T-Lymphocytes" by people in Profiles.
-
LRP-1 links post-translational modifications to efficient presentation of celiac disease-specific T?cell antigens. Cell Chem Biol. 2023 Jan 19; 30(1):55-68.e10.
-
Deaza-modification of MR1 ligands modulates recognition by MR1-restricted T cells. Sci Rep. 2022 12 29; 12(1):22539.
-
Spatial Positioning and Matrix Programs of Cancer-Associated Fibroblasts Promote T-cell Exclusion in Human Lung Tumors. Cancer Discov. 2022 11 02; 12(11):2606-2625.
-
Isolating and targeting a highly active, stochastic dendritic cell subpopulation for improved immune responses. Cell Rep. 2022 11 01; 41(5):111563.
-
Ablation of the endoplasmic reticulum stress kinase PERK induces paraptosis and type I interferon to promote anti-tumor T?cell responses. Cancer Cell. 2022 10 10; 40(10):1145-1160.e9.
-
CXCL9 and CXCL10 bring the heat to tumors. Sci Immunol. 2022 07 22; 7(73):eabq6509.
-
Systematic discovery and perturbation of regulatory genes in human T cells reveals the architecture of immune networks. Nat Genet. 2022 08; 54(8):1133-1144.
-
Now you see me, now you don't: Isolated central nervous system recurrence of CD19-negative diffuse large B-cell lymphoma following CD19-directed CAR T-cell treatment. Cytopathology. 2022 11; 33(6):757-759.
-
Predictors of Covid-19 Vaccination Response After In-Vivo T-Cell-Depleted Stem Cell Transplantation. Transplant Cell Ther. 2022 09; 28(9):618.e1-618.e10.
-
Antibody and T cell responses to COVID-19 vaccination in patients receiving anticancer therapies. J Immunother Cancer. 2022 06; 10(6).